SIGA News and Press, SIGA Technologies Inc. From 05/04/23

NEW YORK, May 04, 2023 (GLOBE NEWSWIRE) -- SIGA Technologies, Inc. (SIGA) (NASDAQ: SIGA), a commercial-stage pharmaceutical company, today announced that the Board of Directors declared a special cash dividend of $0.45 per share on the common stock of the Company. The special cash dividend is pay...

NEW YORK, April 27, 2023 (GLOBE NEWSWIRE) -- SIGA Technologies, Inc. (SIGA) (NASDAQ: SIGA), a commercial-stage pharmaceutical company, today announced that management will host a webcast and conference call to provide a business update at 4:30 P.M. ET on Thursday, May 4 th , 20...

SIGA Technologies, Inc. (SIGA) Q4 2022 Earnings Conference Call March 02, 2023 04:30 PM ET Company Participants Phil Gomez - Chief Executive Officer Dan Luckshire - Chief Financial Officer Conference Call Participants Soo Romanoff - Edison Group Presentat...

SIGA Technologies press release ( NASDAQ: SIGA ): Q4 GAAP EPS of -$0.01. Revenue of $11.4M (-90.1% Y/Y). For further details see: SIGA Technologies GAAP EPS of -$0.01, revenue of $11.4M

- Approximately $71 Million of International Product Sales in 2022 - - Corpor ate Update Conference Call Today at 4:30 PM ET - NEW YORK, March 02, 2023 (GLOBE NEWSWIRE) -- SIGA Technologies, Inc. (SIGA) (NASDAQ: SIGA), a commercial-stage pharmaceutical company...

NEW YORK, Feb. 23, 2023 (GLOBE NEWSWIRE) -- SIGA Technologies, Inc. (SIGA) (NASDAQ: SIGA), a commercial-stage pharmaceutical company, today announced that management will host a webcast and conference call to provide a business update at 4:30 P.M. ET on Thursday, March 2 nd , 2...

Pharmaceutical company SIGA Technologies ( NASDAQ: SIGA ) has announced the planned retirement of CEO Phil Gomez in 2023. Gomez is expected to remain in position as CEO until his successor commences services. The board has initiated a search for a new CEO. For further detail...

NEW YORK, Jan. 17, 2023 (GLOBE NEWSWIRE) -- SIGA Technologies, Inc. (SIGA) (NASDAQ: SIGA), a commercial-stage pharmaceutical company focused on the health security market, today announced that Phil Gomez, PhD, Chief Executive Officer of SIGA, has announced his intention to retire as CEO in 2023. ...

Summary Global and regional cases of the 2022 mpox outbreak are slowly winding down. The company hasn’t reported additional orders for its sole product TPOXX since the third quarter earnings call. Despite the outbreak, SIGA may incredibly have less revenue this year than in 2...

Summary We are downgrading SIGA to a sell rating because of the continued decline in the number of monkeypox cases in the US and the lukewarm retail interest in monkeypox. The lack of a near-term catalyst further complicates the investment case around SIGA. Because monkeypox spreads...